Logo
x

Search

Subscribe Now

Second

FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy

FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy

  • March 17, 2021
AbbVie Report Results of Rinvoq (upadacitinib) in Second P-III Induction Study for Ulcerative Colitis

AbbVie Report Results of Rinvoq (upadacitinib) in Second P-III Induction Study for Ulcerative Colitis

  • February 23, 2021
Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD

Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD

  • November 25, 2020
Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19

Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19

  • June 8, 2020
BD Receives Second FDA's Emergency Use Authorization for its New Molecular Diagnostic Test to Detect COVID-19

BD Receives Second FDA's Emergency Use Authorization for its New Molecular Diagnostic Test to Detect COVID-19

  • April 14, 2020
Boehringer Ingelheim Signs a Second Research Collaboration with Saniona to Develop Therapies Targeting Schizophrenia

Boehringer Ingelheim Signs a Second Research Collaboration with Saniona to Develop Therapies Targeting Schizophrenia

  • March 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.